ANTIBODY FOR TREATING DIABETES AND AUTOIMMUNE DISEASES

Angel Porgador; Ofer Mandelboim; Shlomo Nedvetzki

ANTIBODY FOR TREATING DIABETES AND AUTOIMMUNE DISEASES

Angel Porgador (Inventor), Ofer Mandelboim (Inventor), Shlomo Nedvetzki (Inventor)

The Shraga Segal Department of Microbiology and Immunology

Research output: Patent

Abstract

An isolated antibody comprising an antigen recognition region which comprises six complementarity determining region (CDR) amino acid sequences as set forth in: (i) SEQ ID NOs: 4, 6, 8, 12, 14 and 16; (ii) SEQ ID NOs: 20, 22, 24, 28, 30 and 32; or (iii) SEQ ID NOs: 36, 38, 40, 44, 46 and 48, is disclosed. Methods of producing same as well as pharmaceutical composition comprising same and uses thereof are disclosed.

Original language	English
Patent number	WO2015015489
IPC	A61P 37/ 00 A I
Priority date	30/07/13
State	Published - 5 Feb 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@misc{470b0985f1d54d4189e9d3cd86f24c01,

title = "ANTIBODY FOR TREATING DIABETES AND AUTOIMMUNE DISEASES",

abstract = "An isolated antibody comprising an antigen recognition region which comprises six complementarity determining region (CDR) amino acid sequences as set forth in: (i) SEQ ID NOs: 4, 6, 8, 12, 14 and 16; (ii) SEQ ID NOs: 20, 22, 24, 28, 30 and 32; or (iii) SEQ ID NOs: 36, 38, 40, 44, 46 and 48, is disclosed. Methods of producing same as well as pharmaceutical composition comprising same and uses thereof are disclosed.",

author = "Angel Porgador and Ofer Mandelboim and Shlomo Nedvetzki",

year = "2015",

month = feb,

day = "5",

language = "English",

type = "Patent",

note = "WO2015015489; A61P 37/ 00 A I",

}

TY - PAT

T1 - ANTIBODY FOR TREATING DIABETES AND AUTOIMMUNE DISEASES

AU - Porgador, Angel

AU - Mandelboim, Ofer

AU - Nedvetzki, Shlomo

PY - 2015/2/5

Y1 - 2015/2/5

N2 - An isolated antibody comprising an antigen recognition region which comprises six complementarity determining region (CDR) amino acid sequences as set forth in: (i) SEQ ID NOs: 4, 6, 8, 12, 14 and 16; (ii) SEQ ID NOs: 20, 22, 24, 28, 30 and 32; or (iii) SEQ ID NOs: 36, 38, 40, 44, 46 and 48, is disclosed. Methods of producing same as well as pharmaceutical composition comprising same and uses thereof are disclosed.

AB - An isolated antibody comprising an antigen recognition region which comprises six complementarity determining region (CDR) amino acid sequences as set forth in: (i) SEQ ID NOs: 4, 6, 8, 12, 14 and 16; (ii) SEQ ID NOs: 20, 22, 24, 28, 30 and 32; or (iii) SEQ ID NOs: 36, 38, 40, 44, 46 and 48, is disclosed. Methods of producing same as well as pharmaceutical composition comprising same and uses thereof are disclosed.

M3 - Patent

M1 - WO2015015489

ER -

ANTIBODY FOR TREATING DIABETES AND AUTOIMMUNE DISEASES

Abstract

UN SDGs

Fingerprint

Cite this